Table 2.
Proband I-1 | Proband I-1 | I-2 | II-1 | II-2 | |
---|---|---|---|---|---|
Feature | At presentation | After phosphate treatment | Baseline | Baseline | Baseline |
Age, years | 54 | 55 | 48 | 21 | 19 |
Calcium (8.5 to 10.5 mg/dL) | 8.9 | 9.3 | 9.3 | 9.1 | 9.9 |
Phosphorus (2.5 – 4.5 mg/dL) | 1.7 | 4.4 | 4.1 | 3.8 | 4.5 |
1,25(OH)2 D (21 ng/mL to 65 ng/mL) | 188.2 | 63.2 | 74 | 57 | 62 |
25(OH) D (20–100 ng/mL) | 35 | 43 | 28 | 14 | 11 |
iPTH (10–65 pg/mL) | 18 | 54 | 27 | 34 | 25 |
Creatinine (0.5 to 1.0 mg/dL) | 1.1 | 0.6 | 0.5 | 0.6 | |
Alkaline Phosphatase (39 – 117 IU/L) | 111 | 54 | 65 | 61 | |
24 hour urine calcium | 864 | 402 | 89 | 151 | 80 |
Urine ca/cr ratio (<0.21 mg2/mg2) | 0.64 | 0.25 | 0.15 | 0.15 | 0.18 |
TRP (> 90%) | 60% | 94% | 91% | 93% | |
TmP/GFR (Male 45–55 yrs, 0.9–1.35 mmol/L; Female 45–55 yrs, 0.88–1.44; young females 0.96– 1.5) | 0.33 | 1.5 | 1.2 | 1.5 | |
Genotype | R67H/G191S | R67H/WT | R67H/WT | R67H/G191S |